Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Leclerc

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|May 1, 2016
B cells promote tumor progression in a mouse model of HPV-mediated cervical cancerAlexandre Tang, Gilles Dadaglio, Marine Oberkampf, et al.
Cell Reports|January 31, 2019
Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8<sup>+</sup> T Cell ResponsesCéline Cousin, Marine Oberkampf, Tristan Felix, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell primingSandra Hervas-Stubbs, Jose-Ignacio Riezu-Boj, Uxua Mancheño, et al.
Cell Host & Microbe|April 24, 2012
Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potentialFadel Sayes, Lin Sun, Mariagrazia Di Luca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responsesGilles Dadaglio, Catherine Fayolle, Xiaoming Zhang, et al.
Nature Medicine|April 15, 2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisAlexander S Pym, Priscille Brodin, Laleh Majlessi, et al.
Vaccine|September 7, 2010
Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidisMaika Durantez, Catherine Fayolle, Noelia Casares, et al.
Cancer Research|July 17, 2004
A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primatesRichard Lo-Man, Sophie Vichier-Guerre, Ronald Perraut, et al.
Cancer Research|August 15, 2009
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cellsMagali Terme, Grégoire Mignot, Evelyn Ullrich, et al.
Infection and Immunity|March 23, 2006
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosisLaleh Majlessi, Marcela Simsova, Zdenka Jarvis, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|May 1, 2016
B cells promote tumor progression in a mouse model of HPV-mediated cervical cancerAlexandre Tang, Gilles Dadaglio, Marine Oberkampf, et al.
Cell Reports|January 31, 2019
Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8<sup>+</sup> T Cell ResponsesCéline Cousin, Marine Oberkampf, Tristan Felix, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell primingSandra Hervas-Stubbs, Jose-Ignacio Riezu-Boj, Uxua Mancheño, et al.
Cell Host & Microbe|April 24, 2012
Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potentialFadel Sayes, Lin Sun, Mariagrazia Di Luca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responsesGilles Dadaglio, Catherine Fayolle, Xiaoming Zhang, et al.
Nature Medicine|April 15, 2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisAlexander S Pym, Priscille Brodin, Laleh Majlessi, et al.
Vaccine|September 7, 2010
Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidisMaika Durantez, Catherine Fayolle, Noelia Casares, et al.
Cancer Research|July 17, 2004
A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primatesRichard Lo-Man, Sophie Vichier-Guerre, Ronald Perraut, et al.
Cancer Research|August 15, 2009
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cellsMagali Terme, Grégoire Mignot, Evelyn Ullrich, et al.
Infection and Immunity|March 23, 2006
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosisLaleh Majlessi, Marcela Simsova, Zdenka Jarvis, et al.
Pageof 14